Condition

Autoimmune Diseases (1)

Connective Tissue Diseases (1)

Pathologic Processes (1)

Scleroderma, Diffuse (1)

Scleroderma, Limited (1)

Scleroderma, Systemic (1)

Sclerosis, Progressive Systemic (1)

Skin Diseases (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Cumberland Pharmaceuticals (1)

Collaborator

Intervention

oral ifetroban (1)

oral placebo (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

sclerosis, progressive systemic

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Scleroderma, Diffuse, Scleroderma, Systemic, Scleroderma, Limited Trial in India, United States (Oral Ifetroban, Oral Placebo)

Recruiting

Scleroderma, Diffuse
+7 more

Oral Ifetroban
Oral Placebo

Tucson, Arizona
+15 more

Jun 30, 2022